Phillips Gary M. 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 6, 2024

Form 4

Period: 2024-06-04

Director

Transactions

Award
Stock Option (Right to Buy)
2024-06-04+3,473→ 3,473 total
Exercise: $4.09Exp: 2034-06-03→ Common Stock (3,473 underlying)
Award
Stock Option (Right to Buy)
2024-06-04+40,282→ 40,282 total
Exercise: $4.09Exp: 2034-06-03→ Common Stock (40,282 underlying)
Award
Stock Option (Right to Buy)
2024-06-04+2,604→ 2,604 total
Exercise: $4.09Exp: 2034-06-03→ Common Stock (2,604 underlying)

Footnotes (3)

[F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
[F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.
[F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file